Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "diuretic effect via renal tubule modulation" refers to the pharmacological strategy of inducing increased excretion of water and electrolytes by inhibiting sodium and/or chloride reabsorption in specific segments of the renal tubule. Different diuretic drug classes act on specific channels, transporters, or enzymes in regions such as the proximal convoluted tubule, loop of Henle, distal convoluted tubule, or collecting duct, each affecting fluid and electrolyte balance to treat conditions like hypertension, edema, and heart failure[1][2][3][4][5]. This concept encompasses multiple, well-defined molecular targets—such as the Na+/K+/2Cl- symporter (loop diuretics), Na+/Cl- symporter (thiazides), epithelial sodium channel (ENaC, potassium-sparing), and the mineralocorticoid receptor (aldosterone antagonists)—rather than a single molecule or receptor.
Inhibition of sodium reabsorption at different segments of the renal tubule, Blockade of Na+/K+/2Cl- symporter, Blockade of Na+/Cl- symporter, Inhibition of epithelial sodium channels, Blockade of mineralocorticoid receptor, Inhibition of carbonic anhydrase
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diuretic effect via renal tubule modulation.